
Martin Herman discusses the development of an AI platform for diagnosing cardiovascular conditions and the challenges faced in MedTech fundraising and FDA approval.
In this episode of the Crux of Cardio, host Jordan Burgin is joined by Martin Herman, co-founder and CEO of Powerful Medical the AI-powered cardiac diagnostics company behind PM Cardio. Martin shares how a software engineering background, a medical student brother, and a search for a truly pioneering problem led him to build an AI platform that can now diagnose 46 cardiovascular conditions from a single 12-lead ECG with over 120,000 doctors already using it in clinical practice. They cover the journey from early scepticism to clinical proof, the brutal reality of MedTech fundraising, and what FDA breakthrough designation means for Powerful Medical's imminent US commercial launch. Key Topics: How Powerful Medical identified the ECG as cardiology's biggest unsolved problem Building AI that outperforms experienced cardiologists on the hardest cases The clinical and commercial case for PM Cardio in US heart attack centres FDA breakthrough designation and the road to US approval this summer Raising €46M in non-dilutive EU grant funding and what comes next Winning MedTech Innovator and what it means for partnerships and validation Related Insights: Why starting with the biggest…
Explore listener stats, chart rankings, contacts and more on the The Crux of Medtech podcast page.